Cargando…

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD), an emerging global health problem affecting 25–30% of the total population, refers to excessive lipid accumulation in the liver accompanied by insulin resistance (IR) without significant alcohol intake. The increasing prevalence of NAFLD will lead to an inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Yiming, Lu, Mengna, Xu, Yuan, Wang, Qixue, Gu, Xinyi, Li, Ying, Zhuang, Tongxi, Xia, Chenyi, Zhang, Ting, Gou, Xiao-jun, Zhou, Mingmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271914/ https://www.ncbi.nlm.nih.gov/pubmed/35832821 http://dx.doi.org/10.3389/fmicb.2022.908011

Ejemplares similares

The Impact of Instant Coffee and Decaffeinated Coffee on the Gut Microbiota and Depression-Like Behaviors of Sleep-Deprived Rats
por: Gu, Xinyi, et al.
Publicado: (2022)

Effects of electroacupuncture on urinary metabolome and microbiota in presenilin1/2 conditional double knockout mice
por: Gao, Jie, et al.
Publicado: (2023)

Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in rats
por: Gu, Xinyi, et al.
Publicado: (2022)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
por: Zhang, Yu-Lin, et al.
Publicado: (2022)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Brain Mitochondrial Dysfunction: A Possible Mechanism Links Early Life Anxiety to Alzheimer’s Disease in Later Life
por: Wang, Qixue, et al.
Publicado: (2022)

Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
por: Zhuang, Tongxi, et al.
Publicado: (2021)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
por: Wang, Tianjiao, et al.
Publicado: (2021)

Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids
por: Sun, QinMei, et al.
Publicado: (2022)

Dietary Bile Salt Types Influence the Composition of Biliary Bile Acids and Gut Microbiota in Grass Carp
por: Xiong, Fan, et al.
Publicado: (2018)

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
por: Kumar, Aditi, et al.
Publicado: (2023)

The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity
por: Zhai, Zhenya, et al.
Publicado: (2021)

Urinary metabolomic changes and microbiotic alterations in presenilin1/2 conditional double knockout mice
por: Gao, Jie, et al.
Publicado: (2021)

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
por: Zhang, Xiao-Lei, et al.
Publicado: (2023)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022)

The association between oral and gut microbiota in male patients with alcohol dependence
por: Hu, Lingming, et al.
Publicado: (2023)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease
por: Yu, Jiake, et al.
Publicado: (2021)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
por: Li, Zhonglin, et al.
Publicado: (2023)

Comprehensive Analysis of Gut Microbiota and Fecal Bile Acid Profiles in Children With Biliary Atresia
por: Yang, Ting, et al.
Publicado: (2022)

Integrated network pharmacology and hepatic metabolomics to reveal the mechanism of Acanthopanax senticosus against major depressive disorder
por: Gu, Xinyi, et al.
Publicado: (2022)

Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea
por: Xu, Yayun, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice
por: Hao, Yan, et al.
Publicado: (2022)

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis
por: Grüner, Niklas, et al.
Publicado: (2021)

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
por: Yang, Min, et al.
Publicado: (2021)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

Gut-spine axis: a possible correlation between gut microbiota and spinal degenerative diseases
por: Morimoto, Tadatsugu, et al.
Publicado: (2023)

Gut Microbiota and Relevant Metabolites Analysis in Alcohol Dependent Mice
por: Wang, Guanhao, et al.
Publicado: (2018)

Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions
por: Chen, Ganggang, et al.
Publicado: (2022)

Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
por: Quesada-Vázquez, Sergio, et al.
Publicado: (2020)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases
por: Jiang, Zengliang, et al.
Publicado: (2022)

The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
por: Wu, Yeshun, et al.
Publicado: (2021)

The associations of gut microbiota, endocrine system and bone metabolism
por: Tu, Ye, et al.
Publicado: (2023)

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
por: Wei, Meilin, et al.
Publicado: (2020)

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Mulak, Agata
Publicado: (2021)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Chronic alcohol-induced dysbiosis of the gut microbiota and gut metabolites impairs sperm quality in mice
por: Li, Hui, et al.
Publicado: (2022)

Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials
por: Han, Ting-Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_glatcl56vuaupt0ttnofgoatd6